Blockchain Registration Transaction Record
Annovis Bio to Unveil Alzheimer’s and Parkinson’s Trial Updates in Live Webcast
Annovis Bio announces a live webcast on June 24, 2025, to discuss Phase 3 Alzheimer’s trial and FDA feedback on Parkinson’s program. Learn more about their innovative therapies.

This news is crucial for patients, families, and investors as it highlights Annovis Bio's advancements in treating neurodegenerative diseases. The live webcast offers a rare opportunity to gain insights into potential breakthroughs in Alzheimer’s and Parkinson’s therapies, which could significantly improve the quality of life for millions affected by these conditions. The FDA feedback and Phase 3 trial updates are pivotal steps toward bringing innovative treatments to market.
Blockchain | Details |
---|---|
Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
Transaction ID | 0x77dad19cc63019667c94a96ce9c67c98328c910ee858feb8324502390e7ce717 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | deepN28b-9996171f13c64c2eedb5bc964a8fc901 |